The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 133, No suppl_1, 31S-36S.
© 2002 American Dental Association

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUJOEL, P.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUJOEL, P.P.

ARTICLES

Does chronic periodontitis cause coronary heart disease?

A review of the literature



P.P. HUJOEL, Ph.D.


   ABSTRACT
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
Background. Chronic periodontitis, or CP, has been associated with coronary heart disease, or CHD. This article reviews the available prospective CP-CHD evidence.

Literature Reviewed. In nine cohort studies, CP was associated with a 15 percent greater risk of developing CHD. Conclusions from individual studies depended on study characteristics. Summary risk estimates for studies controlling for smoking intensity (five of nine studies) or health awareness (two of nine studies) or studies with more than 600 CHD events (three of nine studies) suggest that CP is either not at all or weakly associated with CHD. Summary risk estimates for the studies that did not control for these factors or that examined an insufficient number of CHD events reported a weak increase in CHD risk associated with CP (20 percent greater). These data suggest that the CP-CHD associations observed in smaller studies are due to insufficient control for lifestyle differences. In addition, one cohort study reported that edentulous people had a CHD risk similar to that of people with CP. Therefore, the plausibility of dental infection elimination affecting CHD risk appears limited.

Summary. Current evidence supporting a causal CP-CHD link is weak. Rigorous methodological and analytical control of lifestyle factors such as smoking will be required to elucidate whether the CP-CHD disease association is either small or nonexistent.

Clinical Implications. Cigarette smoking destroys both oral and systemic health. Because of this strong common causal factor, oral and systemic health are linked. Dentistry should continue to play an important role in implementing smoking prevention and cessation programs.

The reported increases in the risk of developing coronary heart disease, or CHD, associated with chronic periodontitis, or CP, vary substantially from one study to the next (P < .06). Of the nine studies regarding this topic found in the medicodental literature19 (TableGo), the maximum CHD risk increase associated with CP was 169 percent1; one study reported a 3 percent decrease.2 If this substantial study-to-study heterogeneity were to be ignored, the summary of the nine studies of 94,869 people with 4,105 CHD events would suggest that CP increased CHD risk by 15 percent (95 percent confidence interval, or CI, 1.08 to 1.22). This association is significant, and it may lead those who equate statistical significance with causality to suggest that the association is causal. However, because of the substantial heterogeneity between studies—not only in reported risk estimates, but also in terms of how CP and CHD are defined—the calculation of a summary estimate is questionable. The causes and characteristics of these studies’ heterogeneity merit further investigation.


View this table:
[in this window]
[in a new window]
 
TABLE OVERVIEW OF NINE PROSPECTIVE COHORT STUDIES OF SUBJECTS WITH CHRONIC PERIODONTITIS, OR CP, ON THE LINK BETWEEN CP AND CORONARY HEART DISEASE, OR CHD.

 
The evidence to date supporting the chronic periodontitis–coronary heart disease association is weak.


   HOW STUDY CHARACTERISTICS AFFECT FINDINGS
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
"When you have eliminated the impossible, whatever remains, however improbable, must be the truth," wrote Sir Arthur Conan Doyle. The best approach to discover the "truth" is not to prove a hypothesis, but to attempt to refute it, and to eliminate alternative explanations that may explain the observed associations.10,11 In Feynman’s words, "You should report everything that you think might make it (the hypothesis) invalid ... other causes that could possibly explain your results. In summary, the idea is to give all information."12

What alternative explanations beyond CP may explain the observed CP-CHD association? National U.S. survey data provide some clues to answer this question; people with and without periodontitis differ with respect to factors such as age, socioeconomic status, body mass index, smoking, psychological makeup, cholesterol levels, blood pressure and diabetes.6 Is it possible that studies reporting significant CP-CHD associations had insufficient control for these factors?

Following is a discussion of the impact of three factors—smoking dose, health awareness and sample size—on CP-CHD study conclusions.

Smoking dose. Controlling for smoking history is challenging. Consider the vitamin A–cancer association, for which a dozen case-control and cohort studies suggested that high consumption of carotenoids was associated with a reduced risk of lung cancer.13 Antioxidant vitamins in vegetables and fruits were believed to prevent carcinogenesis and atherogenesis by interfering passively with oxidative damage to DNA and lipoproteins.14 Two large randomized, controlled trials refuted these epidemiologic findings and showed that vitamin A caused (instead of prevented) lung cancer.15,16 What went wrong? How did epidemiologic studies combined with biological plausibility lead to conclusions so inconsistent with randomized trial results?

One explanation is the lack of rigorous control for smoking history.17 As the rigor in controlling for smoking in one epidemiologic study17 increased, the vitamin A–lung cancer association switched from positive to negative. Crude adjustments for smoking history (classification of people as current, never- or former smokers) led to the dubious conclusion that vitamin A reduced the risk of lung cancer by 14 percent.17 In contrast, using the same data and the same analytic methodology but with more rigorous control for smoking history (taking into account smoking intensity, age at start of smoking and age at cessation of smoking) led to the conclusion that high intake of vitamin A increased lung cancer risk by 12 percent.17 Rigorous control for smoking led to a conclusion that was consistent with the results of randomized controlled trials.17

To what extent have the nine cohort studies rigorously controlled for smoking? Currently, no CP-CHD study has had the same level of detailed (that is, rigorous) control for smoking history as the vitamin A–lung cancer research. A summary estimate of the five studies that adjusted somewhat for smoking dose 2,5,6,8,9 suggests that periodontitis is not associated with CHD (relative risk, or RR, 1.05; 95 percent CI, 0.96 to 1.15). The summary estimate of the four studies that either did not adjust for smoking dose or adjusted poorly for smoking1,3,4,7 indicates a positive CP-CHD association (RR, 1.25; CI, 1.15 to 1.37). Lack of control for smoking history is a plausible explanation for the studies that reported significant CP-CHD associations.1,3,4,7

Factors related to health awareness, such as compliance, have a significant impact on disease incidence.

Health awareness. Controlling for health awareness, or the interest in maintaining a healthy lifestyle, is more challenging. Unlike smoking—in which dose, duration and intensity of tobacco consumption can be quantified—no numbers can be attached to health awareness. Yet, health awareness may be equally important. People who do not have gingivitis may be more compliant with oral hygiene recommendations and may have higher health awareness than people who have gingivitis and periodontitis. Such differences in health awareness, when not controlled for, may induce spurious CP-CHD associations.18

Factors related to health awareness, such as compliance, have a significant impact on disease incidence. In a trial of clofibrate, a lipid-lowering drug, subjects compliant with use of the placebo had a 13 percent lower mortality rate than subjects who were not compliant with use of the placebo.19 In a trial of a chlorhexidine varnish aimed at lowering levels of Streptococcus mutans in the mouth, subjects compliant with use of the placebo varnish had a 29 percent lower caries rate than subjects not compliant with use of the placebo.20 In both of these trials, a potential marker for health awareness (compliance with use of placebo) was a powerful indicator of health outcomes. If periodontitis is a marker for poor plaque control and irregular dental care (that is, a lifestyle consistent with poor health awareness), then people with and without periodontitis will differ with respect to CHD incidence, not because of the periodontitis itself but because of the differences in health awareness and behavior.

Control for health awareness can be achieved by selecting populations with a similar educational and socioeconomic status, such as nurses, physicians or dentists. The two studies reporting on populations with similar health awareness8,9 reported no CP-CHD associations (RR, 1.02; 95 percent CI, 0.91 to 1.14). Studies in populations with a more heterogeneous health awareness (that is, representative samples of the U.S. population)17 reported significant CP-CHD associations (RR, 1.21; 95 percent CI, 1.12 to 1.31). These contrasting findings suggest that incomplete control for health awareness may have led to significant CP-CHD associations.

Sample size. Positive results in small studies have a high chance of being false-positive results. Reasons for this trend include the lack of power, publication bias and "investigator’s enthusiasm."21 Among the nine cohort studies located, a nonsignificant trend existed between the number of observed CHD events (directly proportional to power) and the reported CP-CHD association. The three smallest studies1,3,4 all reported significant CP-CHD associations; the second-smallest study,1 which had no control for smoking or age and involved only 68 CHD events, reported the largest CHD risk increase: 169 percent. Among the six larger studies,2,59 only one7 reported a small (25 percent) yet significant CP-CHD association. Studies with more than 600 CHD events6,8,9 reported no CP-CHD associations (RR, 1.05; 95 percent CI, 0.96 to 1.15). Studies with fewer than 600 CHD events15,7 reported a 23 percent CHD risk increase (95 percent CI, 13 to 34 percent). Lack of power may have resulted in false-positive conclusions.


   LIMITATIONS OF EPIDEMIOLOGY AND THE CHRONIC PERIODONTITIS—CORONARY HEART DISEASE ASSOCIATION
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
"People may think they have been able to control for things that are inherently not controllable," wrote Norman Breslow (cited in Taubes22); this quote points to the central limiting factor of epidemiology: an inability to rigorously control for genetic and lifestyle factors, with a consequent inability to detect small risks. A certain amount of arbitrariness is involved in determining what epidemiologists typically mean by small risks, but the following quotations from clinical researchers, gathered by Taubes,22 provide some guidelines.

– Richard Doll, one of the founders of epidemiology: "No single epidemiological study is persuasive by itself unless the lower limit of its 95 percent confidence level falls above a threefold (200 percent) increased risk."
– Dimitrios Trichopoulos, past chair of epidemiology at Harvard: "a fourfold (300 percent) increase [is] the lower limit."
– Marcia Angell, former editor of The New England Journal of Medicine: "As a general rule of thumb, we are looking for a relative risk of 3 or more (> 200 percent increased risk) [before accepting a paper for publication]."
– Robert Temple, associate director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration: "My basic rule is if the relative risk isn’t at least 3 or 4 [a 200 percent or 300 percent increased risk], forget it."
‘One must not verify an idea using the same data that suggested the idea in the first place.’

The size of the risk increase is one of the most important criteria by which epidemiologists judge causality, and the reported CP-CHD associations fall well below the limits of what is considered convincing. If the nine cohort studies had identified associations that fell above some generally accepted limit (for example, > 200 percent), the need for methodological rigor would have been less pressing. Under those circumstances, a more detailed adjustment for smoking or health awareness would have been unlikely to lead to different conclusions. However, since the nine cohort studies located for this review consistently identified small or no risk increases, methodological rigor is essential. Even small errors in the control for smoking history, health awareness or other lifestyle factors can induce biases that are substantially larger than the observed CP-CHD associations.23


   LETTING THE DATA GENERATE THE IDEA
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
"One must not verify an idea using the same data that suggested the idea in the first place ... " Feynman24 wrote. Commonly, when the results of a study are negative (disproving a thesis), investigators explore the data and "discover" associations that appear logical and believable, but that were not specified before the data collection (in other words, the data suggested the ideas). Such ideas are unreliable.

A textbook example regarding the unreliability of data-generated ideas is the research linking coffee drinking and pancreatic cancer. In the 1980s, a study was initiated to determine whether smoking caused pancreatic cancer.25 The results were negative; smoking was found not to be associated with pancreatic cancer. Exploration of the data suggested the idea that coffee drinking was responsible for 50 percent of the pancreatic cancers in the United States.25 However, when this idea was tested in a new study, coffee drinking proved to be harmless. Ideas inferred from data (which is similar to betting on the horse after the race is over) are unreliable and need to be confirmed in other studies.26

In the CP-CHD association, the data obtained have been used to suggest many ideas. For example, negative findings have led to the idea that causal associations do exist for certain subgroups of the population such as people with pre-existing cardiovascular disease,2729 women,30 younger men31 or younger people.32 Another example: negative findings led to the idea that studies of people with self-reported periodontal disease or in whom periodontal disease was diagnosed based on Russell’s Periodontal Index33 are too subjective to show associations. The challenge will be to confirm these data-generated ideas in studies other than "the one that suggested the idea in the first place."


   DO CHRONIC PERIODONTITIS TREATMENTS LOWER CORONARY HEART DISEASE RISK?
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
About 10 percent of fatal cancers may be caused by obesity.34 Peto, the author of the study reporting this finding, indicated in an interview that this does not mean that weight loss programs should be recommended to lower cancer risk.35 No evidence exists to support such a recommendation. Just because a causal characteristic or action produces an effect does not mean one should assume the opposite action would reverse an outcome.

Similarly, if convincing evidence regarding the CP-CHD link would come to light within the next few decades, it would not necessarily imply that CP treatments should be recommended to lower CHD risk (yet, this leap already has been made by some in the dental profession). At least some controlled evidence must be established first to suggest that CP treatments lower CHD risk.

Current evidence from two studies suggests that a complete, definitive and irreversible elimination of dental infections through full-mouth dental extractions does not lower CHD risk36 or C-reactive protein serum levels, a potential mediator of CHD.37 If a complete eradication of dental infections through full-mouth extractions does not provide benefits (and possibly worsens oral health and nutrient intake), why would partial and temporary elimination of infection (in the form of periodontal treatments) provide a CHD-mediating benefit to the patient? Treatment recommendations should be based on controlled evidence, not biological plausibility.


   LOGICAL SIMPLICITY AND BIOLOGICAL PLAUSIBILITY
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
Periodontitis has been inconsistently associated with the diseases that are caused by smoking: coronary heart disease,18 stroke,38 chronic obstructive pulmonary disease,39 malignant neoplasm of the lung,40 low birth weight,41 osteoporosis and diabetes. Providing a unifying and biologically plausible causal explanation for this portfolio of systemic diseases associated with periodontitis is difficult. Different mechanisms have been proposed, and it is unclear which ones are plausible.18 Bacteremia, which occurs with eating, defecating, brushing, breathing, flossing, sex, insect bites and skin scrapes, has been suggested as one culprit. Why periodontal bacteremia in particular would be harmful is unclear.

Interestingly, 8 to 20 square centimeters of periodontal pocket tissue42 have been described in the medicodental literature as "an endocrine organ secreting inflammatory mediators."41 Why other systemic inflammatory diseases, such as rheumatoid arthritis, are not associated with an increased CHD risk is unclear. How either the periodontal "endocrine organ" or the periodontal bacteremia can generate such diverse diseases as cancer, diabetes and CHD is unexplained. Providing a unifying biologically plausible causal explanation consistent with current evidence is challenging and is currently not possible.

In contrast, a unifying and biologically plausible noncausal explanation for these associations is simple: inadequate control for smoking and associated lifestyle factors spuriously induced periodontitis–systemic disease associations. Current epidemiologic evidence, including the lack of a beneficial CHD effect of dental infection elimination, is consistent with such an explanation.


   CONCLUSION
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 
The evidence to date supporting the CP-CHD association is weak. This conclusion is concurrent with two overviews that used different criteria for causality and different study selection criteria.18,43 While there is evidence that acute dental infections, particularly of lower molars, can be fatal,44 there is no convincing evidence that CP affects CHD risk. What has been convincingly demonstrated is that large cohorts with rigorous control for alternative explanations such as lifestyle (most importantly smoking) and genetics will be required to elucidate whether the etiologic role of chronic dental infections in CHD is small or nonexistent.


   FOOTNOTES
 

Dr. Hujoel is an associate professor, Department of Dental Public Health Sciences, School of Dentistry, and an associate professor, Department of Epidemiology, Box 357475, University of Washington, Seattle, Wash. 98195, e-mail "hujoel{at}u.washington.edu". Address reprint requests to Dr. Hujoel.


This report was supported by the National Institutes of Health, Agency for Health Care Policy and Research grants R29-DE12190, P30-DE09743 and R03 DE13861.


   REFERENCES
 TOP
 ABSTRACT
 HOW STUDY CHARACTERISTICS AFFECT...
 LIMITATIONS OF EPIDEMIOLOGY AND...
 LETTING THE DATA GENERATE...
 DO CHRONIC PERIODONTITIS...
 LOGICAL SIMPLICITY AND...
 CONCLUSION
 REFERENCES
 

  1. Genco R, Chadda S, Grossi S, et al. Periodontal disease is a predictor of cardiovascular disease in a Native American population (abstract 3158). J Dent Res 1997;76(special issue):408.

  2. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Pre-existing cardiovascular disease and periodontitis: a follow-up study. J Dent Res 2002;81(3):186–91.[Abstract/Free Full Text]

  3. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infection and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis 1995;20: 588–92.[Medline]

  4. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123–37.[Medline]

  5. Morrison HI, Ellison LF, Taylor GW. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 1999;6(1):7–11.[Medline]

  6. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and coronary heart disease risk. JAMA 2000;284: 1406–10.[Abstract/Free Full Text]

  7. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688–91.[Medline]

  8. Joshipura KJ, Rimm EB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631–6.[Abstract/Free Full Text]

  9. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG. Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 2001;37:445–50.[Abstract/Free Full Text]

  10. Maclure M. Multivariate refutation of aetiological hypotheses in non-experimental epidemiology. Int J Epidemiol 1990;19:782–7.[Abstract/Free Full Text]

  11. Buck C. Popper’s philosophy for epidemiologists. J Epidemiol 1975;4(3):159–68.

  12. Feynman RP. Cargo cult science: some remarks on science, pseudoscience, and learning how to not fool yourself. In: Feynman RP, Robbins J. The pleasure of finding things out. Cambridge, Mass.: Perseus Books; 1999:205–16.

  13. Willett WC. Vitamin A and lung cancer. Nutr Rev 1990;48(5): 201–11.[Medline]

  14. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860–72.[Abstract/Free Full Text]

  15. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5.[Abstract/Free Full Text]

  16. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–35.[Abstract/Free Full Text]

  17. Feskanich D, Ziegler RG, Michaud DS, et al. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst 2000;92:1812–23.[Abstract/Free Full Text]

  18. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999;138:S434–7.[Medline]

  19. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980;303: 1038–41.[Abstract]

  20. Forgie AH, Paterson M, Pine CM, Pitts NB, Nugent ZJ. A randomised controlled trial of the caries-preventive efficacy of a chlorhexidine-containing varnish in high-caries-risk adolescents. Caries Res 2000;34:432–9.[Medline]

  21. Pocock SJ. Clinical trials: A practical approach. New York: Wiley; 1983:239–42.

  22. Taubes G. Epidemiology faces its limits. Science 1995;269(5221): 164–9.[Free Full Text]

  23. Spiekerman C, Hujoel PP, Drangsholt MT, DeRouen TA. Inadequate adjustment for smoking in periodontitis: systemic disease associations (abstract). Ann Periodontol 2001;6(1):222.

  24. Feynman RP, Leighton RB, Sands ML. Six easy pieces: Essentials of physics explained by its most brilliant teacher. Cambridge, Mass.: Perseus Books; 1995:xxi.

  25. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. Coffee and cancer of the pancreas. N Engl J Med 1981;304:630–3.[Abstract]

  26. Feinstein AR. Scientific standards in epidemiologic studies of the menace of daily life. Science 1988;242:1257–63.[Abstract/Free Full Text]

  27. American Academy of Periodontology. Heart disease and stroke. Available at: "www.perio.org/consumer/mbc.heart.htm". Accessed April 22, 2002.

  28. American Academy of Periodontology. Statement on the link between gum disease and heart disease. Available at: "www.perio.org/consumer/webcario.htm". Accessed April 22, 2002.

  29. Fauber J. Infections may hurt your heart: researchers seek reasons for sudden coronary attacks. Milwaukee Journal Sentinel. Dec. 25, 2000; sect 1.

  30. Sternberg S. Gum infections don’t lead to heart disease. USA Today. Sept. 24, 2000; sect 1D.

  31. Rose LF, Steinberg BJ, Minsk L. The relationship between periodontal disease and systemic conditions. Compend Contin Educ Dent 2000;21(10A):870–8.[Medline]

  32. Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M. Age, dental infections, and coronary heart disease. J Dent Res 2000;79:756–60.[Abstract/Free Full Text]

  33. Genco RJ, Trevisan M, Wu T, Beck JD. Periodontal disease and risk of coronary heart disease. JAMA 2001;285(1):40–1.[Free Full Text]

  34. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390–5.[Medline]

  35. Obesity link to cancer. BBC News [Web site]. May 17, 2001. Available at: "news.bbc.co.uk/hi/english/health/newsid_1334000/1334311.stm". Accessed April 25, 2002.

  36. Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Examining the link between coronary heart disease and the elimination of chronic dental infections. JADA 2001;132:883–9.

  37. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79(1):49–57.[Abstract/Free Full Text]

  38. Wu T, Trevisan M, Genco R, Dorn J, Falkner K, Sempos C. Periodontal disease as a risk factor for CVD, CHD, and stroke. Circulation 1999;100:6(P1).

  39. Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol 1998;3:257–61.[Medline]

  40. Hujoel PP, Drangsholt MT, Spiekerman C. Concurrence of periodontitis and cancer (abstract). Ann Periodontol 2001;6(1):222–3.

  41. Offenbacher S, Beck JD, Lieff S, Slade G. Role of periodontitis in systemic health: spontaneous preterm birth. J Dent Educ 1998;62: 852–8.[Medline]

  42. Hujoel PP, White BA, Garcia RI, Listgarten MA. The dentogingival epithelial surface area revisited. J Periodontal Res 2001;36(1): 48–55.[Medline]

  43. Joshipura K, Ritchie C, Douglass C. Strength of evidence linking oral conditions and systemic disease. Compend Contin Educ Dent 2000;21(supplement 28):12–23.

  44. Moczar L. Mortal acute dental infections of oral and dental origin. Dent Cosmos 1933;75:781–9.




This article has been cited by other articles:


Home page
J. Dent. Res.Home page
M.A. Fisher, G.W. Taylor, and K.R. Tilashalski
Smokeless Tobacco and Severe Active Periodontal Disease, NHANES III
J. Dent. Res., August 1, 2005; 84(8): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
K. Buhlin, A. Gustafsson, A.G. Pockley, J. Frostegard, and B. Klinge
Risk factors for cardiovascular disease in patients with periodontitis
Eur. Heart J., December 1, 2003; 24(23): 2099 - 2107.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. Angeli, P. Verdecchia, C. Pellegrino, R. G. Pellegrino, G. Pellegrino, L. Prosciutti, C. Giannoni, S. Cianetti, and M. Bentivoglio
Association Between Periodontal Disease and Left Ventricle Mass in Essential Hypertension
Hypertension, March 1, 2003; 41(3): 488 - 492.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HUJOEL, P.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HUJOEL, P.P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS